PATIENT-INITIATED CLINICAL TRIAL Trademark
Trademark Overview
On Friday, January 16, 2026, a trademark application was filed for PATIENT-INITIATED CLINICAL TRIAL with the United States Patent and Trademark Office. The USPTO has given the PATIENT-INITIATED CLINICAL TRIAL trademark a serial number of 99599127. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, April 29, 2026. This trademark is owned by Clonell Therapeutics, Inc.. The PATIENT-INITIATED CLINICAL TRIAL trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Stem cell therapy services; Medical services, namely, providing patient-specific embryonic stem cell therapies derived from somatic cell nuclear transfer (SCNT); Medical analysis services relating to the treatment of patients; Regenerative medicine services
Medical and scientific research, namely, conducting clinical trials for others; Research and development in the field of pharmaceutical and biotechnology; Platform as a service (PAAS) featuring computer software platforms for escrow-based payment systems for clinical trial verification.
General Information
| Serial Number | 99599127 |
| Word Mark | PATIENT-INITIATED CLINICAL TRIAL |
| Filing Date | Friday, January 16, 2026 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, April 29, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Stem cell therapy services; Medical services, namely, providing patient-specific embryonic stem cell therapies derived from somatic cell nuclear transfer (SCNT); Medical analysis services relating to the treatment of patients; Regenerative medicine services |
| Goods and Services | Medical and scientific research, namely, conducting clinical trials for others; Research and development in the field of pharmaceutical and biotechnology; Platform as a service (PAAS) featuring computer software platforms for escrow-based payment systems for clinical trial verification. |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 16, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 16, 2026 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Clonell Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Uiwang-si 16012
KR |
Trademark Events
| Event Date | Event Description |
| Friday, January 16, 2026 | NEW APPLICATION ENTERED |
| Friday, January 16, 2026 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, January 21, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 27, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, April 29, 2026 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 29, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, April 29, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
